Announced Mon, 27 Apr · 19:30 IST
MOA amended to enable bonus share issue; authorised capital increased
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹0.43
prior close
₹0.42
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.4+2.4+2.4+2.4-2.3-7.0-7.0-9.3-4.7-9.3-14.0-16.3-25.6—
Up moveDown movePending
AI summary
Biogen Pharmachem Industries received shareholder approval via postal ballot (notice dated 23 March 2026) for issuing bonus shares and increasing its authorised share capital. The company has amended the capital clause of its Memorandum of Association to reflect this change. Bonus ratio and record date are not specified in this filing.
Likely market impact
Bonus shares will expand total share count, typically lowering per-share price proportionally. No cash outflow, but no added value for shareholders either.